TY  - GEN
AU  - Anderson,P M
AU  - Meyers,P
AU  - Kleinerman,E
AU  - Venkatakrishnan,K
AU  - Hughes,D P
AU  - Herzog,C
AU  - Huh,W
AU  - Sutphin,R
AU  - Vyas,Y M
AU  - Shen,V
AU  - Warwick,A
AU  - Yeager,N
AU  - Oliva,C
AU  - Wang,B
AU  - Liu,Y
AU  - Chou,A
TI  - Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
SN  - 1545-5017
PY  - 2014///0225
KW  - Acetylmuramyl-Alanyl-Isoglutamine
KW  - administration & dosage
KW  - Adolescent
KW  - Adult
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Child
KW  - Child, Preschool
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunologic Factors
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Grading
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Osteosarcoma
KW  - Phosphatidylethanolamines
KW  - Prognosis
KW  - Safety
KW  - Survival Rate
KW  - Tissue Distribution
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/pbc.24686
ER  -